Frontlight ResearchEarly access
Hidradenitis suppurativa trials in United States
27 of 36 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleRollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Where
- Albuquerque, Ann Arbor, Auburn Hills, Baltimore, Baton Rouge, Bellaire, Bexley, Birmingham, Boca Raton, Boston, Bowling Green, Brighton, Chapel Hill, Chicago, Cincinnati, Columbus, Coral Gables, Cumming, Dallas, Danville, Detroit, Dublin, East Syracuse, El Paso, Farmington, Fountain Valley, Fremont, Glenn Dale, Hialeah, Hollywood, Huntington Beach, Indianapolis, Irvine, Laguna Niguel, Leawood, Los Angeles, Marietta, Miami, Miami Lakes, Mill Creek, Minneapolis, Missoula, Montgomery, New Orleans, New York, Norfolk, North Miami Beach, Northridge, Oakland, Ocala, Oklahoma City, Philadelphia, Phoenix, Plano, Plymouth Meeting, Portsmouth, Richmond, Rochester, Rockville, Saint Joseph, San Antonio, Sandy Springs, Santa Monica, Seattle, Sherman Oaks, Skokie, South Jordan, Spokane, St Louis, Stonecrest, Sunnyvale, Tampa, Troy, Tucson, Waterford, Webster, West Dundee, West Lafayette, West Palm Beach
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06855498 · EU 2024-520107-12-00 - Phase 2Taking peoplePharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Where
- Albuquerque, Auburn Hills, Baltimore, Bellaire, Birmingham, Boston, Bowling Green, Dallas, Danville, Detroit, El Paso, Farmington, Leawood, Miami, Missoula, Phoenix, Sandy Springs, Skokie, South Jordan, St Louis, Tampa, Troy
- Age
- 12 years to 17 years
- People
- 40 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07213973 - Phase 2Taking peopleEfficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity
- Where
- The Bronx
- Age
- 18 years and over
- People
- 300
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07830329 · EU 2026-526375-39-00 - Phase 1Taking peopleA Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HS
- Where
- Mayfield Heights, San Diego
- Age
- 18 years to 65 years
- People
- 30
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07855276 · EU 2025-524222-18-00 - Phase 3Taking peopleAn Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Where
- Birmingham, Boardman, Charleston, Fort Smith, Fremont, Glenview, Huntersville, Los Angeles, Mayfield Heights, Miami, New Albany, New York, North Little Rock, Omaha, Pittsburgh, Rochester, San Antonio, Sylmar, Tampa, Thousand Oaks, Troy, Vienna, Webster, West Dundee
- Age
- 18 years to 100 years
- People
- 710 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07665437 · EU 2025-523259-72-00 - Phase 2Taking peopleA Study to Investigate Efficacy and Safety of Duvakitug in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Where
- Birmingham, Miami
- Age
- 18 years and over
- People
- 156 worldwide
- Run by
- Sanofi
See details and how to joinNCT07812116 - Phase 2Taking peopleORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Where
- Baton Rouge, Birmingham, Canton, Chapel Hill, Chicago, Cromwell, Dallas, Fountain Valley, Los Angeles, Missouri City, New Brighton, New Orleans, New York, Omaha, Plainfield, Portland, San Antonio, Sandy Springs, Smyrna, St Louis
- Age
- 18 years to 79 years
- People
- 200 worldwide
- Run by
- Oruka Therapeutics, Inc.
See details and how to joinNCT07783542 - Phase 2Taking peopleA Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
- Where
- Atlanta, Baton Rouge, Birmingham, Boston, Bowling Green, Coral Gables, Detroit, Durham, Indianapolis, Irvine, Las Vegas, Mill Creek, Mt. Pleasant, Murray, Nashville, New York, Oklahoma City, Owensboro, Prosper, Rogers, Smyrna, The Bronx, Tyler
- Age
- 18 years to 75 years
- People
- 150 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07766005 - Phase 2Taking peopleA Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Where
- Boston, Boynton Beach, Cumming, Evansville, Fayetteville, Fort Lauderdale, Fort Myers, Hollywood, Kansas City, Louisville, Miami, Norfolk, North Hollywood, Scottsdale, Skokie, Tampa, The Bronx, The Woodlands, Tulsa
- Age
- 18 years and over
- People
- 144 worldwide
- Run by
- Sanofi
See details and how to joinNCT07225569 · EU 2025-522695-83-00 - Phase 1Taking peopleSafety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Where
- Boston, Bowling Green, Camp Hill, Fargo, Mayfield Heights, Nashville, New York, Owensboro, Philadelphia, The Bronx, West Lafayette
- Age
- 18 years and over
- People
- 25
- Run by
- Corvus Pharmaceuticals, Inc.
See details and how to joinNCT07828860 - Phase 2Taking peopleBrivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- Where
- Atlanta, Baton Rouge, Chapel Hill, Dallas, Fort Myers, Johnston, Las Vegas, Miami, Miramar, Myrtle Beach, New York, Northridge, Phoenix, Savannah, Scottsdale, St Louis, West Des Moines
- Age
- 18 years and over
- People
- 208 worldwide
- Run by
- Sanofi
See details and how to joinNCT07170917 · EU 2025-522333-61-00 - Phase 2Taking peopleSafety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa
- Where
- Missouri City
- Age
- 12 years and over
- People
- 10
- Run by
- Harrison Dermatology
See details and how to joinNCT07689188 - Phase 1Taking peopleStudy to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Where
- Baton Rouge, Bolivar, Bowling Green, Castle Rock, Columbus, Fargo, Fountain Valley, New York, Northridge, Oklahoma City, Orange, Philadelphia, Phoenix, Sanford, Sweetwater, Tampa, Thousand Oaks, Troy, West Lafayette
- Age
- 12 years to 75 years
- People
- 24
- Run by
- Incyte Corporation
See details and how to joinNCT07049575 - Phase 1Taking peopleA Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Where
- Boston, Chapel Hill, Durham, Milwaukee, Santa Monica, South Miami
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00 - Phase 2Not yet taking people in United StatesBotulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa
- Where
- Worcester
- Age
- 13 years to 75 years
- People
- 40
- Run by
- University of Massachusetts, Worcester
See details and how to joinNCT07756346 - Early phase 1Taking peopleCapsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 16
- Run by
- University of Minnesota
See details and how to joinNCT06058520 - No phaseNot yet taking people in United StatesMediterranean Dietary Intervention for HS
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 30
- Run by
- University of North Carolina, Chapel Hill
See details and how to joinNCT07800416 - Early phase 1Taking peopleEvaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
- Where
- Birmingham
- Age
- 18 years and over
- People
- 12
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06326476 - Phase 2Taking peopleA Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
- Where
- Boston, Maitland, Miami, Murray, North Miami Beach, Phoenix, Portsmouth, Ridgeland, Scottsdale, Tamarac, Tampa, The Bronx
- Age
- 18 years to 70 years
- People
- 150 worldwide
- Run by
- Navigator Medicines, Inc.
See details and how to joinNCT07384975 · EU 2025-523557-33-00 - Phase 2Taking peopleThe Safety and Efficacy of Roflumilast Foam in HS
- Where
- Boston
- Age
- 18 years and over
- People
- 20
- Run by
- Beth Israel Deaconess Medical Center
See details and how to joinNCT07263230 - Phase 3Enrolling by invitationA Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa
- Where
- Ann Arbor, Aventura, Birmingham, Boardman, Boston, Canton, Clarkston, Columbus, Coral Gables, Dallas, Dayton, Fargo, Hialeah, Hollywood, Houston, Las Vegas, Los Angeles, Louisville, Macon, Metairie, Miami, Mill Creek, Morgantown, Murfreesboro, Murray, New Albany, New Brighton, New York, North Little Rock, Northridge, Ocala, Oklahoma City, Omaha, Plainfield, San Antonio, Sandy Springs, Skokie, South Jordan, Tampa, The Bronx, Waterford, West Dundee
- Age
- 12 years and over
- People
- 835 worldwide
- Run by
- MoonLake Immunotherapeutics AG
See details and how to joinNCT07007637 - No phaseTaking peoplePelashield™ PainGuard™ vs Restrata® in HS Surgery
- Where
- Newark
- Age
- 18 years and over
- People
- 10
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT07316192 - No phaseTaking peopleRadiotherapy for Refractory Hidradenitis Suppurativa
- Where
- Cherry Hill, Philadelphia
- Age
- 18 years and over
- People
- 10
- Run by
- Thomas Jefferson University
See details and how to joinNCT07414550 - Phase 1Taking people1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)
- Where
- Rosemead
- Age
- 18 years to 60 years
- People
- 30
- Run by
- Wynn Medical Center
See details and how to joinNCT07155239 - Phase 2Taking peopleA Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
- Where
- Ann Arbor, Sacramento
- Age
- 18 years to 75 years
- People
- 60
- Run by
- AbbVie
See details and how to joinNCT06524635